Crossmark

The transition of medication overuse status by acute medication categories in episodic or chronic migraine patients to non-overuse status after receiving anti-CGRP monoclonal antibodies: a systematic review and meta-analysis of phase 3 randomized control trial

Crossref DOI link: https://doi.org/10.1007/s10072-024-07496-7

Published Online: 2024-04-02

Published Print: 2024-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sirilertmekasakul, Chananchida

Panto, Akkanat

Lekhalawan, Pattanan

Panyarachun, Pariyada

Jindasakchai, Porpim

Rattanawong, Wanakorn https://orcid.org/0000-0001-7277-9699
License Information

Text and Data Mining valid from 2024-04-02

Version of Record valid from 2024-04-02
More Information

Article History

Received: 6 February 2024

Accepted: 23 March 2024

First Online: 2 April 2024

Declarations

:

: Our study is a systematic review and meta-analysis, and thus does not require ethical approval.

: N/A.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below